Cite

HARVARD Citation

    Merriman, J. et al. (n.d.). Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma. Journal of immunotherapy. 39 (2), p. . [Online]. 
  
Back to record